Reneo Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RPHM and other ETFs, options, and stocks.

About RPHM

Reneo Pharmaceuticals, Inc. is a clinical-stage company, which engages in the research and development of therapies for rare genetic mitochondrial diseases. The company was founded by Michael G. 

CEO
Gregory J. Flesher
CEOGregory J. Flesher
Employees
48
Employees48
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
2014
Founded2014
Employees
48
Employees48

RPHM Key Statistics

Market cap
55.13M
Market cap55.13M
Price-Earnings ratio
-0.70
Price-Earnings ratio-0.70
Dividend yield
Dividend yield
Average volume
165.04K
Average volume165.04K
High today
$1.68
High today$1.68
Low today
$1.64
Low today$1.64
Open price
$1.66
Open price$1.66
Volume
33.76K
Volume33.76K
52 Week high
$11.30
52 Week high$11.30
52 Week low
$0.9801
52 Week low$0.9801

Analyst ratings

83%

of 6 ratings
Buy
0%
Hold
83.3%
Sell
16.7%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.